EDGAR Filing Documents for 0001171843-20-005516

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001171843-20-005516

Filing Date

2020-08-05

Accepted

2020-08-05 12:29:42

Documents

Period of Report

2020-06-11

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	f6k_080420.htm	6-K	10045
2	EXHIBIT 99.1	exh_991.htm	EX-99.1	265717
3	EXHIBIT 99.2	exh_992.htm	EX-99.2	250434
4	EXHIBIT 99.3	exh_993.htm	EX-99.3	6615
5	EXHIBIT 99.4	exh_994.htm	EX-99.4	6679
6	EXHIBIT 99.5	exh_995.htm	EX-99.5	13192
7	EXHIBIT 99.6	exh_996.htm	EX-99.6	8619
8	EXHIBIT 99.7	exh_997.htm	EX-99.7	53588
9		logo.jpg	GRAPHIC	5354
	Complete submission text file	0001171843-20-005516.txt		623358

Mailing Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2

Business Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2 416 648-5555

Medicenna Therapeutics Corp. (Filer) CIK: 0001807983 (see all company filings)